SINGAPORE, Nov. 10, 2019 /PRNewswire/ -- Stone Capital and Biosyngen have partnered to establish a Biopharmaceutical Investment Fund in Singapore, the signing ceremony was held in Ascendas One Hub of China-Singapore Guangzhou Knowledge City. The key investment targets of the...
from PR Newswire: https://ift.tt/2q1rk7Z
No comments:
Post a Comment